Skip to main content
. 2016 Oct 18;26(10):1059–1071. doi: 10.1093/glycob/cww053

Table II.

IL-1β-induced presentation of cell surface PSGL-1 in the presence and absence of compound 1

Time (h) Treatment PSGL-1 levels
IL-1β IL-1β + cmpd 1
0 16.7 ± 6.6 16.7 ± 6.6 MFI
24 13.9 ± 2.1 8.4 ± 1.3 MFI
48 22.2 ± 3.7 10.4 ± 2.1 MFI
72 44.2 ± 10.0 13.8 ± 4.1 MFI